Localização do estoque

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Estoque sujeito a disponibilidade

Documentation

Baixar MSDS

Baixar COA de amostra

Inclui: HPLC, MASS/LC-MS, RMN de 1H, FT-IR, teor, Relatório de Elucidação Estrutural (SER) e dados analíticos adicionais dependendo do produto.

N-Nitroso Upadacitinib (Possibility 2)

● Em Estoque

Nº do catálogo:	VE0024987
Nº CAS:	N/A
Fórmula Mol.::	C17H18F3N7O2
Peso Mol.::	409.4 g/mol

Solicitar orçamento

Adicionar à lista de RFQ

Informações adicionais sobre o N-Nitroso Upadacitinib (Possibility 2)

Fármaco de origem

Upadacitinib

Nome IUPAC

(3S, 4R)-3-ethyl-4-(3H-imidazo[1, 2-a]pyrrolo[2, 3-e]pyrazin-8-yl)-N-nitroso-N-(2, 2, 2-trifluoroethyl)pyrrolidine-1-carboxamide

Sinônimos farmacopeicos

N/A

Outros sinônimos

N/A

SMILES

O=C(N1C[C@@H](CC)[C@@H](C2=CN=C3C=NC(NC=C4)=C4N32)C1)N(N=O)CC(F)(F)F

InChI

InChI=1S/C17H18F3N7O2/c1-2-10-7-25(16(28)26(24-29)9-17(18, 19)20)8-11(10)13-5-22-14-6-23-15-12(27(13)14)3-4-21-15/h3-6, 10-11, 21H, 2, 7-9H2, 1H3/t10-, 11+/m1/s1

Descrição

N-Nitroso Upadacitinib (Possibility 2) is an N-nitroso derivative of the secondary amine present in Upadacitinib | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of Upadacitinib production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.